Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

July 16, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • FEATURED
  • COVID: One in every four persons have Covid-19 Antibodies in Kolkata

MythLysis: "Genetically modified crops: Harmful index reality check"

COVID UPDATE: AstraZeneca’s Covid-19 vaccine trials to be resumed again

COVID: One in every four persons have Covid-19 Antibodies in Kolkata
  • BiotechToday
  • FEATURED
  • India
  • Latest

COVID: One in every four persons have Covid-19 Antibodies in Kolkata

bioxone September 12, 2020September 12, 2020

-Sayak Biswas, Amity University, Kolkata

During a time when the coronavirus is spreading like a wildfire across the whole world, a private laboratory in West Bengal has claimed that one in every four persons have Covid-19 Antibodies in Kolkata. This news has come as a relief to a State which has already seen over 1.87 lakh novel coronavirus cases including 3715 deaths till date.

The private laboratory claimed that it has done a sero survey among 3.5 lakh people across India recently. From West Bengal, a total of 22589 people was brought under this program and from Kolkata itself, 9050 people were included. Based on the study, the laboratory confirmed that at least 26 percent of the population of Kolkata and around 23 percent of the population of Bengal may have already developed Covid-19 antibodies while the National numbers stand at 27 percent. If this trend continues, experts feel herd immunity will be achieved faster than thought.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged corona virus Covid KOLKATA WEST BENGAL

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • FEATURED
  • India
  • Latest
  • World

COVID UPDATE: AstraZeneca’s Covid-19 vaccine trials to be resumed again

bioxone September 12, 2020

-Anuska Sen, Team bioXone On 10th September 2020, that is 2 days back, Team BioXone had covered a piece of news stating the pause of the Covid-19 vaccine of AstraZeneca by Serum Institute. Today, it has been reported that once again, the trials for AstraZeneca’s Covid-19 vaccine has been successfully resumed. The one reason that […]

Related Post

  • BiotechToday
  • World

Is Greenland really melting?

bioxone February 9, 2021February 9, 2021

Sampriti Roy, University of Calcutta “When the ocean speaks, the Greenland Ice Sheet listens,” said Oceans Melting Greenland’s Principal Investigator Josh Willis. The image above presents a finding that is definitely a step forward in terms of research and rather worrying in terms of the current climate crisis. The image captured by Operational Land Imager […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

J&J COVID-19 vaccine: A potential disaster for humans

bioxone July 14, 2021July 14, 2021

Saptaparna Dasgupta, Bennett University The COVID-19 vaccine has been created as an emergency vaccine, based on several strategies, such as mRNA vaccine, inactivated virus vaccine, etc. The other vaccines having cleared the clinical trials have passed on to the mass population vaccination drives, without any reported risk factors, yet. However, Johnson and Johnson’s COVID 19 […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • India
  • Latest

Genetic analysis of Rosmaric acid synthase from O. tenuiflorum using the magical molecular toolbox.

bioxone September 5, 2020September 5, 2020

–Anwita Sarkar, Amity University Kolkata The impact of advancement of molecular biotechnology across the nation can be applied to code/ decode the intricate biological system. Its immense applications provide excellent opportunities to the present-day biologists to answer each and every possible biological problem. Scientists are able to acquire a better understanding of the important metabolites […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy